Related Experiment Video

Updated: Jul 6, 2025

Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

6.6K

Hsp Inhibitor is Affective Against Adenocarcinomic Human Alveolar Basal Epithelial Cells Through Modulating ERK/MAPK

Servet Tunoğlu1, Lütfi Tutar2, Mehmet Gümüş3

  • 1Department of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.

Chemistry & Biodiversity
|December 29, 2023
PubMed

Insights

Novel perimidine-pyrazole compounds inhibit cancer cell survival by targeting the ERK-MAPK pathway and Heat Shock Protein 90 (HSP90). These compounds show promise as anticancer drugs for non-small cell lung cancer (NSCLC).

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • The extracellular signal-regulated kinase (ERK) - mitogen-activated protein kinase (MAPK) pathway is crucial for cell regulation.
  • Heat Shock Protein 90 (HSP90) promotes tumor growth and survival in non-small cell lung cancer (NSCLC) by activating oncogenic kinases and inhibiting apoptosis.
  • Deregulation of the ERK-MAPK pathway and abnormal HSP90 expression are common in NSCLC.

Purpose of the Study:

  • To investigate novel perimidine-pyrazole compounds as inhibitors of ERK-MAPK pathway deregulation.
  • To evaluate the effects of these compounds on HSP90-dependent cancer cell survival mechanisms in NSCLC.
  • To explore the potential of these compounds as templates for developing new anticancer drugs.

Main Methods:

  • Synthesis and testing of novel perimidine-pyrazole derivatives on an NSCLC cell line.
  • Gene enrichment analysis of array experiments to understand pathway modulation.
  • Senescence and apoptosis assays to confirm cellular effects.
  • In silico methods to predict perimidine-pyrazole/HSP90 interactions.

Main Results:

  • Perimidine-pyrazole derivatives demonstrated cancer-inhibitory effects on NSCLC cells.
  • Compounds induced pro-senescence and pro-apoptotic effects.
  • Inhibition of cancer cell survival was mediated through the ERK/MAPK pathway.
  • In silico analysis supported interactions between compounds and HSP90.

Conclusions:

  • Novel perimidine-pyrazole compounds effectively inhibit NSCLC cell growth.
  • These compounds target cancer cell survival via the ERK/MAPK pathway and HSP90.
  • Perimidine-pyrazole derivatives represent promising candidates for future anticancer drug development.
Keywords:
A549ApoptosisHSPNSCLCPerimidine-pyrazoleSenescence

More Related Videos

RNA Interference-based Investigation of the Function of Heat Shock Protein 27 during Corneal Epithelial Wound Healing08:34

RNA Interference-based Investigation of the Function of Heat Shock Protein 27 during Corneal Epithelial Wound Healing

Published on: September 27, 2016

7.5K
Efficient Transcriptionally Controlled Plasmid Expression System for Investigation of the Stability of mRNA Transcripts in Primary Alveolar Epithelial Cells10:49

Efficient Transcriptionally Controlled Plasmid Expression System for Investigation of the Stability of mRNA Transcripts in Primary Alveolar Epithelial Cells

Published on: March 6, 2020

6.0K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K